46 research outputs found
Integrating technology into cognitive behavior therapy for adolescent depression: a pilot study
Effectiveness of Pregabalin as Monotherapy or Combination Therapy for Neuropathic Pain in Patients Unresponsive to Previous Treatments in a Spanish Primary Care Setting
Perceived facilitators and barriers to self-management in individuals with traumatic spinal cord injury: a qualitative descriptive study
Effectiveness of enhanced cognitive behavioral therapy (CBT-E) for eating disorders: study protocol for a randomized controlled trial
Population structure and connectivity in Indo-Pacific deep-sea mussels of the Bathymodiolus septemdierum complex
Discriminant validity of the MASQ in a clinical sample
A major weakness of the Mood and Anxiety Symptom Questionnaire (MASQ) is that its discriminant validity has not been demonstrated in a clinical population of anxiety and mood disorder patients. This paper, using 470 anxiety and mood disorder patients, assessed the discriminant validity of the MASQ. The MASQ subscales showed statistically significant discriminant validity, but their maximum ability to discriminate is low at 70%. Overall it was concluded that the MASQ had very weak clinical utility in differentiating anxiety and mood disorder patients, and gave rise to doubts as to the tripartite structure of the MASQ. When using the MASQ, future researchers should be mindful of its limitations when applied in a clinical population. (c) 2006 Elsevier Ireland Ltd. All rights reserved